The study aims to compare the overall survival adjusted to quality of life of 2 groups of patients with multiple myeloma, depending on the type of care: (1) day hospitalization exclusively or (2) day hospitalization combined with hospital-at-home. As secondary objectives, the study aims to compare the impacts of the two types of care organization on: * the survival of patients and response to treatments according to criteria of the International Myeloma Working Group, * psychological status of patients, * specific toxicity related to treatment used (haematological and infectious toxicity, neurotoxicity, ...), * health outcomes, * the caregiver's burden, This study is combined with a qualitative study about the incentives and the barriers, and in order to set up the patient's typology.
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Quality of life using questionnaires EORTC QLQ-30
Timeframe: At baseline, at the 6th month and the 12th month
Change in Quality of life using questionnaires EORTC QLQ-MY20
Timeframe: At baseline, at the 6th month and the 12th month
Bénédicte MITTAINE-MARZAC, PharmD